Skip to main content
IDEXX Laboratories, Inc. (IDXX)
NASDAQ: IDXX · Real-Time Price · USD
418.61
+2.27 (0.55%)
Nov 20, 2024, 4:00 PM EST - Market open

IDEXX Laboratories Revenue

IDEXX Laboratories had revenue of $975.54M in the quarter ending September 30, 2024, with 6.56% growth. This brings the company's revenue in the last twelve months to $3.84B, up 7.16% year-over-year. In the year 2023, IDEXX Laboratories had annual revenue of $3.66B with 8.72% growth.

Revenue (ttm)
$3.84B
Revenue Growth
+7.16%
P/S Ratio
9.01
Revenue / Employee
$349,529
Employees
11,000
Market Cap
34.28B

Revenue Chart

History

Fiscal Year End Revenue Change Growth
Dec 31, 20233.66B293.63M8.72%
Dec 31, 20223.37B151.96M4.73%
Dec 31, 20213.22B508.71M18.79%
Dec 31, 20202.71B299.75M12.45%
Dec 31, 20192.41B193.67M8.75%
Dec 31, 2018 Pro Pro Pro
Dec 31, 2017 Pro Pro Pro
Dec 31, 2016 Pro Pro Pro
Dec 31, 2015 Pro Pro Pro
Dec 31, 2014 Pro Pro Pro
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
Cardinal Health 224.45B
Centene 146.20B
Humana 115.01B
IQVIA Holdings 15.32B
ResMed 4.81B
DexCom 3.95B
Mettler-Toledo International 3.76B
Veeva Systems 2.57B
Revenue Rankings

IDXX News

More News